Form: 10-Q

Quarterly report pursuant to Section 13 or 15(d)

COMPUTATION OF NET INCOME (LOSS) PER SHARE

Published on



EXHIBIT 11.1

SONUS PHARMACEUTICALS, INC.
COMPUTATION OF NET INCOME (LOSS) PER SHARE


<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
------------------------------- ------------------------------
1997 1996 1997 1996
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Net income (loss) ............................... $(1,122,176) $ 2,801,745 $ 639,604 $ (925,037)
=========== =========== =========== ===========



Weighted average shares outstanding ............. 8,573,029 8,490,201 8,573,029 8,467,100

Net effect of common stock equivalents
using the treasury stock method ............ -- 640,790 593,861 --
----------- ----------- ----------- -----------

Shares used in computation of net
income (loss) per share .................... 8,573,029 9,130,991 9,166,890 8,467,100
----------- ----------- ----------- -----------


Net income (loss) per share ..................... $ (0.13) $ 0.31 $ 0.07 $ (0.11)
=========== =========== =========== ===========




</TABLE>